Fight disinformation. Get a daily recap of the facts that matter. Sign up for the free Mother Jones newsletter.


Do you want a quick summary or all the gory details? The details, of course. Because, really, what’s better than listening to an acquaintance ramble on about their health issues?

So: My M-protein marker test—a good proxy for the level of cancerous bone marrow cells—is down from 0.72 last month to 0.63 this month. This is the right direction, but not the right magnitude. So we’re going to increase my Revlimid maintenance from 10 mg to 15 mg. This puts at me at a slightly higher risk of blood clots, which means that I will also be starting a daily baby aspirin regimen.

Blood clots aside, the main side effect of the Revlimid is that it weakens your immune system. This is measured primarily by looking at your neutrophil count. Yours is probably around 5000 or so. Mine is now down to 1800. Anything above 1000 is OK, but obviously this is getting close to worrisome. So now we’re doing a balancing act: we want to use the highest dose of Revlimid that still keeps me out of the immune system red zone. It will take several months to figure out what that is.

And speaking of this, it turns out that following the stem cell transplant I now have what’s effectively a baby immune system. This means that in a month or so I’ll start going through all the usual baby immunizations. Not all, actually, but a bunch. Fun.

On a positive note, apparently my bones are in good enough shape that I’ll be allowed to do strenuous stuff if my back fully recovers. So that’s something to look forward to. Assuming my back ever fully recovers, of course.

And finally, a test to see if my sister reads all the way to the end: I now have permission to clean the cat litter box. So you don’t need to come over tonight.

ONE MORE QUICK THING:

Or at least we hope. It’s fall fundraising time, and we’re trying to raise $250,000 to help fund Mother Jones’ journalism during a shorter than normal three-week push.

If you’re reading this, a fundraising pitch at the bottom of an article, you must find our team’s reporting valuable and we hope you’ll consider supporting it with a donation of any amount right now if you can.

It’s really that simple. But if you’d like to read a bit more, our membership lead, Brian Hiatt, has a post for you highlighting some of our newsroom's impressive, impactful work of late—including two big investigations in just one day and covering voting rights the way it needs to be done—that we hope you'll agree is worth supporting.

payment methods

ONE MORE QUICK THING:

Or at least we hope. It’s fall fundraising time, and we’re trying to raise $250,000 to help fund Mother Jones’ journalism during a shorter than normal three-week push.

If you’re reading this, a fundraising pitch at the bottom of an article, you must find our team’s reporting valuable and we hope you’ll consider supporting it with a donation of any amount right now if you can.

It’s really that simple. But if you’d like to read a bit more, our membership lead, Brian Hiatt, has a post for you highlighting some of our newsroom's impressive, impactful work of late—including two big investigations in just one day and covering voting rights the way it needs to be doneā€”that we hope you’ll agree is worth supporting.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate